Results 31 to 40 of about 1,907 (170)

Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients

open access: yesJournal of Microbiology, Immunology and Infection, 2023
Objectives: To assess associations between disease severity in index TB patients and QuantiFERON-TB Gold Plus (QFT-Plus) results in contacts, and predictors for QFT-Plus conversion in contacts over 6–12 months.
Sheng-Wei Pan   +11 more
doaj   +1 more source

665. Lower Indeterminate Rates and Resolution by Retesting Using a Single Lithium-Heparin Tube Blood Collection Method for the QuantiFERON®-TB Gold Plus (QFT®-Plus) [PDF]

open access: yesOpen Forum Infectious Diseases, 2020
Abstract Background The QuantiFERON-TB Gold Plus (QFT-Plus) test is an assay for detecting a cell-mediated immune response to M. tuberculosis (MTB). The assay measures the in vitro quantitative IFN-γ responses to MTB or control antigens in an incubated blood sample.
Clark, Richard B   +6 more
openaire   +1 more source

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease

open access: yesPulmonology, 2022
Objective: 1) to compare the QIAreachTM QuantiFERON-TB (QIAreach QFT) vs. QuantiFERON®-TB Gold Plus assay (QFT-Plus) to detect tuberculosis (TB) infection; 2) to evaluate diagnostic sensitivity of QIAreach QFT using active TB as surrogate for TB ...
K. Fukushima   +5 more
doaj   +3 more sources

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion. [PDF]

open access: yesTranspl Infect Dis
This study comparing 4‐month rifampin with 9‐month isoniazid for latent tuberculosis in kidney transplant candidates showed higher treatment completion rates and no transaminase elevations in the rifampin group. However, some patients experienced an increase in blood pressure while taking antihypertensive medications known to interact with rifampin ...
Simkins J   +13 more
europepmc   +2 more sources

Magnitude and associated factors of latent tuberculosis infection due to Mycobacterium tuberculosis complex among high-risk groups in urban Bobo-Dioulasso, Burkina Faso [PDF]

open access: yes, 2022
Objectives: To determine the prevalence and risk factors for latent tuberculosis infection (LTBI) among three high-risk groups - household contacts of TB index cases, healthcare workers and slaughterhouse workers - in Bobo-Dioulasso, Burkina Faso ...
Addo, K. K.   +14 more
core   +1 more source

Comparing the performance of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube among highly TB exposed gold miners in South Africa [PDF]

open access: yes, 2021
Background: QuantiFERON-TB-Gold-in-tube (QFT-GIT) is an interferon-gamma release assay (IGRA) used to diagnose latent tuberculosis infection. Limited data exists on performance of QuantiFERON-TB Gold-Plus (QFT-Plus), a next generation of IGRA that ...
Charalambous, Salome   +11 more
core   +2 more sources

P164 Qft-plus: do the peptides in the tb2 tube induce a t suppressor response in some subjects? [PDF]

open access: yesEarly detection and screening in TB, 2017
Introduction The revised QuantiFERON-TB Gold assay (QFT-Plus) has an extra tube (TB2), containing peptides thought to stimulate CD8 +T cells; TB7 antigen is no longer included. The test is designed to detect latent tuberculosis infection. Hypothesis Levels of interferon-γ in TB2 should always be greater than TB1 Methods QFT-Plus was used routinely
M Sieren   +4 more
openaire   +1 more source

Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases [PDF]

open access: yes, 2021
We compared the results and differences of indeterminate rates between the QuantiFERON-TB Gold In-Tube (QFT-GIT) and QuantiFERON-TB Gold PLUS (QFT-PLUS) tests in patients with rheumatic diseases and analyzed the associated factors.
김형우, 박윤희, 안성수
core   +1 more source

Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.

open access: yesPLoS ONE, 2020
BackgroundWe investigated changes in the interferon-γ levels before and after treatment of latent tuberculosis infection (LTBI) using QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON-TB Gold In-Tube (QFT-GIT) assays.
Ock-Hwa Kim   +6 more
doaj   +1 more source

Comparative evaluation of QuantiFERON-TB Gold Plus for diagnosis of latent tuberculosis infection during solid organ transplantation

open access: yesKorean Journal of Transplantation, 2020
Background : The diagnosis of latent tuberculosis infection (LTBI) in solid organ transplantation (SOT) patients under lifelong immunosuppression has profound effects on preoperative and postoperative management.
Sun Joo Yoon   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy